Beijing Tong Ren Tang Chinese Medicine Company Limited (Tong Ren Tang CM) filed its Monthly Return for the period ended 31 March 2026, confirming a stable share structure and full compliance with Hong Kong Stock Exchange requirements.
Issued Share Capital • Ordinary shares in issue remained unchanged at 837.10 million, with zero treasury shares reported. • No share repurchases, cancellations, or new issuances occurred during the month.
Public Float Status • The company affirmed that it met the Main Board minimum public-float threshold of 25% as at 31 March 2026.
Capital Instruments • No outstanding or newly granted share options, warrants, convertible securities, or other equity-linked instruments were recorded.
Regulatory Confirmation • The submission, dated 02 April 2026 and signed by the Company Secretary, attests that all statutory and listing-rule obligations were satisfied during the reporting period.